irinotecan has been researched along with Neoplasms, Pleural in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aigner, C; Bankfalvi, A; Hegedüs, B; Hegedüs, L; Mairinger, F; Okumus, Ö; Ploenes, T; Reuter, S; Schuler, M; Theegarten, D; Vega-Rubin-de-Celis, S; Welt, A | 1 |
| Fukita, S; Saitoh, M; Takeda, S; Takeda, T | 1 |
| Antonuzzo, A; Bocci, G; Bursi, S; Chiara, S; Del Tacca, M; Di Paolo, A; Falcone, A; Fornaro, L; Loupakis, F; Masi, G; Pfanner, E; Vasile, E | 1 |
| Dhaliwal, K; Evans, MT; Fennell, DA; Gower, N; Parmar, A; Rudd, R; Shamash, J; Sheaff, MT; Steele, J; Sylvester, R | 1 |
| Green, MR; Herndon, JE; Kindler, HL; Zhang, C | 1 |
| Fujii, Y; Nakazawa, K; Shuzui, Y; Yoneto, T | 1 |
| Nakano, T | 1 |
| Evans, MT; Fennell, DA; Rudd, RM; Shamash, J; Sheaff, MT; Stebbing, J; Steele, JP; Wells, P | 1 |
| Fuyuno, G; Horio, H; Kobayashi, R; Morinaga, S; Nomori, H | 1 |
| Halme, M; Jekunen, A; Kivisaari, L; Knuuttila, A; Linnainmaa, K; Mali, P; Mattson, K; Ollikainen, T | 1 |
1 review(s) available for irinotecan and Neoplasms, Pleural
| Article | Year |
|---|---|
[Malignant mesothelioma--diagnosis and treatment strategies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asbestos; Camptothecin; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Humans; Interleukin-6; Irinotecan; Mediastinal Neoplasms; Mesothelioma; Pleural Neoplasms; Tomography, X-Ray Computed | 2006 |
2 trial(s) available for irinotecan and Neoplasms, Pleural
| Article | Year |
|---|---|
Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Disease Progression; Female; Heart Neoplasms; Humans; Infusions, Intravenous; Irinotecan; Mesothelioma; Middle Aged; Peritoneal Neoplasms; Pleural Neoplasms; Survival Analysis; Treatment Outcome | 2005 |
Docetaxel and irinotecan (CPT-11) in the treatment of malignant pleural mesothelioma--a feasibility study.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Feasibility Studies; Female; Humans; Irinotecan; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Pleural Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2000 |
7 other study(ies) available for irinotecan and Neoplasms, Pleural
| Article | Year |
|---|---|
TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy.
Topics: Cell Line, Tumor; Humans; Immunoconjugates; Irinotecan; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; RNA | 2023 |
Small cell carcinoma presenting with massive pleural spread mimicking malignant pleural mesothelioma.
Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Cisplatin; Diagnosis, Differential; Fatal Outcome; Humans; Irinotecan; Male; Mesothelioma; Neoplasm Recurrence, Local; Pleural Effusion, Malignant; Pleural Neoplasms; Small Cell Lung Carcinoma | 2014 |
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Fluorouracil; Humans; Irinotecan; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Pleural Neoplasms; Survival Rate; Treatment Outcome; Young Adult | 2009 |
Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Logistic Models; Male; Mesothelioma; Middle Aged; Mitomycin; Models, Theoretical; Organoplatinum Compounds; Oxaliplatin; Pleural Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Vinblastine; Vinorelbine | 2005 |
[A case of pericardial tamponade caused by recurrent breast cancer treated with intrapericardial and intrapleural infusion of cisplatin (CDDP)].
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Carcinoma, Ductal, Breast; Cardiac Tamponade; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Infusions, Intralesional; Irinotecan; Pericardial Effusion; Pericardiocentesis; Pleural Effusion, Malignant; Pleural Neoplasms | 2006 |
Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Female; Humans; Irinotecan; Male; Mesothelioma; Middle Aged; Mitomycin; Pleural Neoplasms; Quality of Life; Survival Rate; Treatment Outcome | 2007 |
[Long-term survival after multimodal therapy for lung cancer with pleural dissemination].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Pleural Neoplasms; Radiosurgery; Survivors | 1997 |